Recent & Archived News
June 19, 2019
Bayer's Stivarga® (regorafenib) becomes first compound used in clinical trial platform to investigate new therapies for brain cancer
Bayer announced today that the Stivarga® (regorafenib) arm of the platform trial GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) has opened enrollment for patients with...
June 19, 2019
Bayer Donation of $45,000 Helped Fund Development of Cook Museum of Natural Science
The Environmental Science business of Bayer is honored to have contributed $45,000 toward the development of the new Cook Museum of Natural Science that opened on June 7 in Decatur, AL. The museum...
June 17, 2019
Bayer Launches Blue Ribbon Beekeepers, Announces Feed a Bee Grants to Celebrate National Pollinator Week
The Bayer Bee Care Program is celebrating National Pollinator Week by honoring those who are working hard to support bees and other pollinators around the country. The company announced Blue...
June 11, 2019
Bayer Donates $50,000 to the Association of Foreign Correspondents in the United States
Bayer announces today its new partnership with the newly formed Association of Foreign Correspondents in the United States (AFC) that will provide present and future generations of journalists the...
June 10, 2019
Ranchland Managers Have a New Tool to Fight Invasive Annual Grass
Ranchland managers who have long worried about the quality of forage available for their livestock have a new tool to fight the invasive annual grasses medusahead and ventenata. Esplanade® 200...
June 07, 2019
Stop Invasive Annual Grasses from Destroying Western Ecosystems
An invader has been moving across the Western United States, degrading wildlife habitat, putting protected and threatened species like the Sage Grouse and desert tortoise at risk, reducing...
June 04, 2019
Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants
Bayer today announced a collaboration with Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company based in New Haven, Connecticut. The new life science research partnership uniquely leverages...
June 03, 2019
New data on Vitrakvi® (larotrectinib) in TRK fusion cancer patients with brain metastases or primary central nervous system (CNS) tumors
Bayer today announced results of a new analysis from clinical trials investigating Vitrakvi® (larotrectinib) in patients with TRK fusion cancer with primary central nervous system (CNS) tumors or...
May 30, 2019
Win the battle against scab and other wheat diseases with an 8.2 oz/A rate of Prosaro
Cereal diseases like scab affect grain quality and yield and rob wheat growers of profitability year after year. But growers can fight back and win with Prosaro® fungicide. The timely application...
May 29, 2019
Bayer and Foundation Medicine announce global collaboration to develop next-generation sequencing (NGS)-based companion diagnostics in oncology
Bayer AG and Foundation Medicine, Inc. today announced a global collaboration for the development and commercialization of NGS-based companion diagnostics. This agreement allows for collaboration...
Want even more Bayer news?
Last Updated: December 14, 2018